Condition-Specific Health
Anti-TLR4 Monoclonal Antibody Shows Promise in Acute Kidney Injury
TLR4 pathway modulation is drawing renewed attention as a therapeutic target in immuno-inflammatory conditions — with i…
Condition-Specific Health 84 stories
Condition-Specific Health
IV Ketamine Outperforms Nasal Esketamine in Real-World MDD Data
Yale and Osmind researchers bring peer-reviewed real-world data to the ketamine therapy debate, with implications for c…
Condition-Specific Health
CREXONT Levodopa Data: What Formulators Should Know
Extended-release carbidopa/levodopa advances in Phase 4 — a signal for the broader controlled-release delivery science …
Condition-Specific Health
Lomitapide EU Approval Expands to Pediatric Rare Lipid Disorder
The EC label expansion targets an ultra-rare genetic LDL disorder — a reminder of how orphan-drug pipelines intersect w…
Condition-Specific Health
Orelabrutinib BTK Inhibitor Posts Safety Data in SLE Phase IIb
Data presented at EULAR 2026 add to the growing clinical record for targeted immunology compounds with potential nutrac…
Condition-Specific Health
Non-Invasive Glucose Monitoring Market Eyes 25.6% CAGR Through 2034
A tenfold market expansion over ten years is reshaping how brands position glycemic-support ingredients and finished fo…
Condition-Specific Health
Nervous System-Centered Recovery Model Gains Traction in Arizona
Forward-Facing® Accelerated Recovery positions autonomic nervous system modulation at the center of residential addicti…
Condition-Specific Health
MindBio Intox AI Detects Impairment via Voice Analytics
As employers expand functional wellness protocols, AI-driven impairment screening tools are entering the occupational h…
Condition-Specific Health
Alzheimer's Awareness Month Drives Brain Health Supplement Demand
Free memory screenings nationwide signal growing consumer engagement with cognitive wellness — a category analysts peg …
Condition-Specific Health
CAR T-Cell Therapy Data Highlights Gap in Nutraceutical Autoimmune Space
As pharmaceutical pipelines advance on autoimmune fronts, formulators eye immune-balancing botanicals and specialized n…
Condition-Specific Health
Noom RCT: Weight Loss Sustained 52 Weeks Post-Program
Peer-reviewed RCT data may shift how operators and formulators think about behavioral programs as a clinical-grade weig…
Condition-Specific Health
Daré Bioscience Launches Flora Sync LF5™ Vaginal Probiotic Capsule
The launch signals growing operator interest in condition-specific probiotic delivery formats targeting vaginal microbi…